Quoin Pharmaceuticals Ltd - American Depositary Shares — Quarterly Financial Statistics (NASDAQ:QNRX) | MetaTrader

Open full chart

Financials

Overview Relevé Statistics

Quarterly Annual

Cash from operating activities -2.24 M-2.59 M-3.69 M-2.23 M-5.04 M -13.54 M Cash from investing activities -3.18 M2.77 M1.68 M2.54 M-11.27 M -4.28 M Cash from financing activities 5.92 M22.96 K-150 K-150 K18.29 M 18.01 M Free cash flow -2.24 M-2.59 M-3.69 M-2.23 M-5.04 M -13.54 M

Nouvelles

Quoin indique que la FDA pourrait accepter une seule étude de phase 3

La FDA accorde le statut de procédure accélérée au médicament de Quoin contre le syndrome de Netherton

FDA grants fast track status to Quoin’s Netherton Syndrome drug

Quoin seeks orphan drug status in Japan for Netherton Syndrome therapy

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.22%

L’action de Quoin Pharmaceuticals s’envole après avoir atteint les concentrations cibles de rapamycine

Quoin Pharmaceuticals stock soars after achieving target rapamycin loadings

Quoin atteint les concentrations cibles de rapamycine pour les traitements cutanés

Quoin achieves target rapamycin concentrations for skin treatments

US Stocks Mixed; Sea Shares Gain After Q3 Results - MSP Recovery (NASDAQ:MSPR), Outset Medical (NASDAQ:OM)

Le cours de Quoin Pharmaceuticals en hausse après des données positives d’essais pédiatriques

Quoin Pharmaceuticals stock rises after positive pediatric trial data